Hsiao K, Dlouhy S R, Farlow M R, Cass C, Da Costa M, Conneally P M, Hodes M E, Ghetti B, Prusiner S B
Department of Neurology, University of California, San Francisco 94143-0518.
Nat Genet. 1992 Apr;1(1):68-71. doi: 10.1038/ng0492-68.
Two families with Gerstmann-Sträussler-Scheinker disease (GSS) are atypical in possessing neocortical neurofibrillary tangles (NFTs), which are few or absent in other kindreds with GSS, in addition to amyloid plaques that react with prion protein (PrP) antibodies and protease-resistant PrP accumulation in the brain. A leucine substitution at PrP codon 102 has been genetically linked to GSS in some families. We examined the PrP gene in these families. A serine for phenylalanine substitution was found at codon 198 in the Indiana patients; arginine for glutamine substitution at codon 217 in the Swedish patients. These mutations in PrP are the first to be associated with the appearance of both PrP amyloid plaques and neocortical NFTs in GSS patients.
两个患有格斯特曼-施特劳斯勒-谢inker病(GSS)的家族具有非典型性,除了与朊病毒蛋白(PrP)抗体发生反应的淀粉样斑块以及大脑中抗蛋白酶的PrP积累外,还存在新皮质神经原纤维缠结(NFTs),而在其他GSS家族中这种缠结很少或不存在。在某些家族中,PrP密码子102处的亮氨酸替代已与GSS存在基因关联。我们对这些家族的PrP基因进行了检测。在印第安纳州的患者中,密码子198处发现苯丙氨酸被丝氨酸替代;在瑞典患者中,密码子217处发现谷氨酰胺被精氨酸替代。PrP中的这些突变首次与GSS患者中PrP淀粉样斑块和新皮质NFTs的出现相关联。